|
Velo Biosciences, Inc. (EVLO) Valoración de DCF |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Evelo Biosciences, Inc. (EVLO) Bundle
¡Explore las perspectivas financieras de Evelo Biosciences, Inc. (EVLO) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones para el crecimiento, los márgenes y los gastos para determinar el valor intrínseco de Evelo Biosciences, Inc. (EVLO) e informar sus decisiones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2018 |
AY2 2019 |
AY3 2020 |
AY4 2021 |
AY5 2022 |
FY1 2023 |
FY2 2024 |
FY3 2025 |
FY4 2026 |
FY5 2027 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -58.1 | -86.4 | -91.9 | -115.4 | -106.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .0 | .0 | 2.0 | 2.2 | 2.1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -58.1 | -86.4 | -93.9 | -117.6 | -108.4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | 147.9 | 77.8 | 68.9 | 68.4 | 47.9 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 1.5 | .6 | 1.4 | 1.6 | 1.8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -5.5 | -3.0 | -1.3 | -1.5 | -.6 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | -0.81868 | -0.81868 | -0.81868 | -0.81868 | -0.81868 | -0.81868 | -0.81868 | -0.81868 | -0.81868 | -0.81868 |
| EBITAT | -55.0 | -86.6 | -94.3 | -118.0 | -109.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -58.9 | -90.5 | -92.8 | -117.2 | -107.7 | -1.8 | .0 | .0 | .0 | .0 |
| WACC, % | 8.64 | 9.14 | 9.14 | 9.14 | 9.14 | 9.04 | 9.04 | 9.04 | 9.04 | 9.04 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | 3 | |||||||||
| Equity Value | -5 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | -1.10 |
What You Will Get
- Pre-Filled Financial Model: Evelo Biosciences' actual data facilitates accurate DCF valuation.
- Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
- Instant Calculations: Real-time updates guarantee you see outcomes as you adjust inputs.
- Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
- Customizable and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.
Key Features
- Comprehensive Financial Data: Gain access to precise historical data and future forecasts tailored for Evelo Biosciences, Inc. (EVLO).
- Adjustable Forecast Parameters: Modify highlighted fields such as WACC, growth rates, and profit margins to fit your analysis.
- Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Utilize clear charts and summaries to easily interpret your valuation findings.
- Designed for All Skill Levels: An intuitive layout suitable for investors, CFOs, and consultants alike.
How It Works
- Download the Template: Gain immediate access to the Excel-based EVLO DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Evelo's intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
- Analyze and Decide: Leverage the results to inform your investment or financial analysis.
Why Choose This Calculator for Evelo Biosciences, Inc. (EVLO)?
- Precision: Utilizes accurate financial data specific to Evelo Biosciences.
- Adaptability: Allows users to easily adjust and experiment with various inputs.
- Efficiency: Bypass the complexities of creating a DCF model from the ground up.
- Expert-Level: Crafted with the insight and precision expected at the CFO level.
- Intuitive: Simple interface suitable for users without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Evaluate Evelo Biosciences’ valuation prior to making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and validate financial forecasts.
- Startup Founders: Understand the valuation strategies of biotech companies like Evelo.
- Consultants: Provide detailed valuation analyses and reports for clients in the biotech sector.
- Students and Educators: Utilize real-time data to learn and teach valuation practices in biotechnology.
What the Template Contains
- Pre-Filled Data: Incorporates Evelo Biosciences' historical financials and projections.
- Discounted Cash Flow Model: Customizable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for computing WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Evelo's profitability, efficiency, and financial leverage.
- Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
- Clear Dashboard: Visualizations and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.